Corso A - Search Results

1

Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.

Corso A, Castelli G, Pagnucco G, Lazzarino M, Bellio L, Klersy C, Bernasconi C. Corso A, et al. Haematologica. 1997 Jan-Feb;82(1):43-6. Haematologica. 1997. PMID: 9107081

2

Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy.

Corso A, Nozza A, Lazzarino M, Klersy C, Zappasodi P, Arcaini L, Bernasconi C. Corso A, et al. Haematologica. 1999 Apr;84(4):336-41. Haematologica. 1999. PMID: 10190948

3

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.

Corso A, Arcaini L, Mangiacavalli S, Astori C, Orlandi E, Lorenzi A, Passamonti F, Klersy C, Pascutto C, Canevari-Sciorati A, Lazzarino M. Corso A, et al. Haematologica. 2001 Apr;86(4):394-8. Haematologica. 2001. PMID: 11325645

4

A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma.

Corso A, Arcaini L, Caberlon S, Zappasodi P, Mangiacavalli S, Lorenzi A, Rusconi C, Troletti D, Maiocchi MA, Pascutto C, Morra E, Lazzarino M. Corso A, et al. Haematologica. 2002 Oct;87(10):1041-5. Haematologica. 2002. PMID: 12368158

5

The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma.

Corso A, Barbarano L, Zappasodi P, Cairoli R, Alessandrino EP, Mangiacavalli S, Ferrari D, Fava S, Fiumanò M, Frigerio G, Isa L, Luraschi A, Klersy C, De Paoli A, Vergani C, Banfi L, Perego D, Ucci G, Pinotti G, Savarè M, Uziel L, Vismara A, Morra E, Lazzarino M. Corso A, et al. Haematologica. 2004 Sep;89(9):1124-7. Haematologica. 2004. PMID: 15377474 Clinical Trial.

6

Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection.

Corso A, Varettoni M, Mangiacavalli S, Zappasodi P, Klersy C, Rusconi C, Colucci E, Lorenzi A, Troletti D, Consensi E, Lazzarino M. Corso A, et al. Leuk Res. 2005 Feb;29(2):159-63. doi: 10.1016/j.leukres.2004.05.018. Leuk Res. 2005. PMID: 15607364

7

Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment.

Corso A, Ferretti E, Lazzarino M. Corso A, et al. Hematology. 2005 Jun;10(3):215-24. doi: 10.1080/10245330500094714. Hematology. 2005. PMID: 16019470 Free article. Review.

8

Changes in multiple myeloma epidemiology in the last thirty years: a single centre experience.

Zappasodi P, Corso A, Klersy C, Pica G, Mangiacavalli S, Varettoni M, Rusconi C, Pascutto C, Lazzarino M. Zappasodi P, et al. Among authors: corso a. Eur J Cancer. 2006 Feb;42(3):396-402. doi: 10.1016/j.ejca.2005.09.031. Epub 2006 Jan 5. Eur J Cancer. 2006. PMID: 16403623

9

The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.

Castagnola C, Nozza A, Corso A, Bernasconi C. Castagnola C, et al. Among authors: corso a. Haematologica. 1997 Sep-Oct;82(5):577-80. Haematologica. 1997. PMID: 9407724 Clinical Trial.

10

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.

Lazzarino M, Orlandi E, Klersy C, Astori C, Brusamolino E, Corso A, Bellio L, Gargantini L, Morra E, Bernasconi C. Lazzarino M, et al. Among authors: corso a. Cancer. 1998 Feb 1;82(3):576-82. Cancer. 1998. PMID: 9452277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters